MedPath

Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis

Completed
Conditions
Dry Eye Syndromes
Rheumatoid Arthritis
Registration Number
NCT02252744
Lead Sponsor
Western University of Health Sciences
Brief Summary

This study will evaluate the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis. No treatment is administered in this study.

Detailed Description

We investigated the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis by information sheets and direct recruitment of patients of potential study participants diagnosed with rheumatoid arthritis. Subjective assessment for dry eye disease was performed using Ocular Surface Disease Index (OSDI) questionnaire. The following objective tests of dry eye disease were employed: tear osmolarity (TO), tear break-up time (TBUT), corneal fluorescein staining score and conjunctival lissamine green staining scores using the National Eye Institute-recommended grading system, and Schirmer without anesthetic. The Dry Eye Severity Grading Scheme highlighted by the Dry Eye WorkShop was adapted to quantify dry eye disease severity level.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
286
Inclusion Criteria
  • Diagnosed with rheumatoid arthritis
  • 18 years old or older
  • Speaks and understands English and/or Spanish
Exclusion Criteria
  • Unable to provide consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Participants Diagnosed With Rheumatoid Arthritis Also Found to Have Dry Eye Disease1 day
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath